iRhythm Holdings, Inc. (NASDAQ:IRTC)
| Market Cap | $3.18B-48.3% |
| Revenue (ttm) | $854.04M+21.6% |
| Net Income | -$38.59M+25.0% |
| EPS | -$1.17+27.4% |
| Shares Out | 33.62M |
| PE Ratio | n/a |
| Forward PE | 74.24 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 875,302 |
| Open | $96.76 |
| Previous Close | $94.24 |
| Day's Range | $93.01 - $96.76 |
| 52-Week Range | $82.85 - $192.47 |
| Beta | 1.40 |
| Analysts | Buy |
| Price Target | $169.63(+79.09%) |
| Earnings Date | Feb 18, 2027 |
About IRTC
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
iRhythm Holdings, Inc. Stock Analysis — InsiderScore
iRhythm Holdings, Inc. scored higher than 69% of companies evaluated by InsiderBuying, and ranked 19th out of 56 stocks in the healthcare sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at iRhythm Holdings, Inc. bought $763.7K of stock across 1 purchase in the last 90 days, the largest of them $763.7K.
None of these purchases could be measured against an existing holding, so this part of the factor scores on dollars alone.
1 of these purchases was made by someone who held no stock at all beforehand — going from nothing to a position is the strongest form of this signal.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
11 firms rating IRTC in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 18, 2027Earnings report
$IRTC stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of IRTC by members of U.S. Congress
| Richard BlumenthalSenate / D | Sale$1.00K – $15.00K | Aug 14, 2025 |
| Donna ShalalaHouse | Sale$1.00K – $15.00K | Jun 24, 2019 |
Recently reported changes in IRTC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by IRTC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
IRTC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New IRTC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to IRTC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in IRTC
| VTIVanguard Morningstar Total Stock Market ETF | $99.96M |
| VBVanguard Morningstar Small-Cap ETF | $89.41M |
| IWMiShares Russell 2000 ETF | $84.03M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $50.05M |
| VXFVanguard Extended Market ETF | $46.21M |
| IWOiShares Russell 2000 Growth ETF | $29.46M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from IRTC’s recent data — informational, not investment advice
What’s Behind the Score
News check: Bullish share repurchase announcements and insider buying offset by analyst downgrade despite revenue growth.
Recent Insider Activity
Insider Score Trend Over Time
+41.4 since Aug 21Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| EDOC | Global X Telemedicine & Digital Health ETF | 4.56% |
| FDHT | FIDELITY DIGITAL HEALTH ETF | 2.58% |
| HEAL | Global X HealthTech ETF | 2.30% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 1.19% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 1.19% |
| MEDI | Harbor Health Care ETF (MEDI) | 0.94% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 0.89% |
| FFOX | FundX Future Fund Opportunities ETF | 0.85% |
| GSC | Goldman Sachs Small Cap Equity ETF | 0.67% |
| HART | NYLI Healthy Hearts ETF | 0.56% |
| NTRL | First Trust Merger Arbitrage ETF | 0.55% |
| SMDC | Nomura Small and Mid Cap ETF | 0.55% |
Weight is the stock’s share of each fund’s holdings.
